bioRxivImmunology
Profound Treg perturbations correlate with COVID-19 severity
S. Galvan-Pena, J. Leon, K. Chowdhary, D. A. Michelson, B. Vijaykumar, L. Yang, A. Magnuson, Z. Manickas-Hill, A. Piechocka-Trocha, D. P. Worrall, K. E. Hall, M. Ghebremichael, B. D. Walker, J. Z. Li, X. G. Yu, MGH COVID-19 Collection & Processing Team, D. Mathis, C. Benoist
Abstract
The hallmark of severe COVID-19 disease has been an uncontrolled inflammatory response, resulting from poorly understood immunological dysfunction. We explored the hypothesis that perturbations in FoxP3+ T regulatory cells (Treg), key enforcers of immune homeostasis, contribute to COVID-19 pathology. Cytometric and transcriptomic profiling revealed a distinct Treg phenotype in severe COVID-19 patients, with an increase in both Treg proportions and intracellular levels of the lineage-defining transcription factor FoxP3, which correlated with poor outcomes. Accordingly, these Tregs over-expressed a range of suppressive effectors, but also pro-inflammatory molecules like IL32. Most strikingly, they acquired similarity to tumor-infiltrating Tregs, known to suppress local anti-tumor responses. These traits were most marked in acute patients with severe disease, but persisted somewhat in convalescent patients. These results suggest that Tregs may play nefarious roles in COVID-19, via suppressing anti-viral T cell responses during the severe phase of the disease, and/or via a direct pro-inflammatory role.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis
B. Kalfaoglu, J. Almeida-Santos, … M. Ono·bioRxiv·May 26, 2020
- Impaired function and delayed regeneration of dendritic cells in COVID-19
E. Winheim, L. Rinke, … A. B. Krug·bioRxiv·May 26, 2021
- T cell activation, highly armed cytotoxic cells and a sharp shift in monocytes CD300 receptors expression is characteristic of patients with severe COVID-19
O. Zenarruzabeitia, G. Astarloa-Pando, … F. Borrego·bioRxiv·Dec 22, 2020
- Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
A. J. Wilk, M. J. Lee, … C. A. Blish·bioRxiv·Dec 18, 2020
- The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
H. Bolouri, C. Speake, … BRI COVID-19 Research Team·bioRxiv·Sep 18, 2020
- Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection
J. Graham, J. Swarts, … J. M. Lund·bioRxiv·Sep 21, 2020